Adial Announces Appointment of Tony Goodman as Chief Operating Officer
Charlottesville, Va., Jan. 18, 2024 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced the appointment of Tony Goodman as Chief Operating Officer.
Related news for (ADIL)
- Adial Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
- Adial Pharmaceuticals Completes Successful EOP2 FDA Meeting
- Today’s Top Performers: MoBot’s Market Review 07/29/25 08:00 AM
- Today’s Top Performers: MoBot’s Market Review 07/28/25 04:00 PM
- Don’t Miss Out: MoBot’s Latest Stock Updates 07/28/25 11:00 AM